Castik Capital, a Luxembourg-based private equity investment firm, announced the final close of its third fund, EPIC III, with total capital commitments of €2...
Lian Group, a Luxembourg-based provider of a healthcare investment platform, acquired Scientis, a Geneva, Switzerland-based cosmeceutical company.
The amount of the deal was not disclosed
This acquisition strengthens and expands Lian's footprint in...
Gcore, a Luxembourg-based edge AI, cloud, network, and security solutions provider, raised $60M in Series A funding.
The round was led by Wargaming, and with...
Columna Capital, a lower mid-market private equity firm investing in Western Europe, closed Columna Capital Fund III, at €290M.
Columna Fund III attracted institutional and...
The CareVoice, a Luxembourg-based embedded health enabler for insurers, raised nearly $10M in Series B funding.
The round was led by Apis Insurtech Fund I.
The...
Accenture (NYSE: ACN) is to acquire Arηs (pronounced Aris) Group, a Luxembourg based technology services provider focused on supporting public sector transformation across Europe.
The...
Alter Domus, a Luxembourg-based provider of end-to-end tech-enabled fund administration, private debt, and corporate services for the alternative investment industry, received an investment from...
Paladin Capital Group, a multi-stage investor specializing in cyber, AI, and advanced technology, launched the Paladin Global Institute with Kemba Walden, former Acting National Cyber...
Databourg, a Luxembourg-based environmental data analytic startup, raised $1M in Seed funding.
The round was led by Asian Development Bank (ADB) Ventures.
The company intends to...
Maor Investments, a Luxembourg-based venture capital firm dedicated to Israeli technologies, closed its second fund, Maor II, at $180M.
Maor is exclusively focused on investing...
Circu Li-ion, a Luxembourg-based battery recycling startup, raised €8.5M in Seed funding.
The recent funding included €4.5m in equity, which was led by BonVenture and...
Vesalius Biocapital, a Luxembourg-based specialist life sciences venture capital investor, announced the first close of its fourth fund, Vesalius Biocapital IV, securing over €95m...
